ArticleNature communications2026
Acute sleep rebound following sleep restriction is associated with reduced mortality risk.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- The use ofFrontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Public health guidelines recommend 7-9 hours of regular sleep and suggest weekend catch-up sleep after weekday sleep deficits. However, real-world sleep patterns are more complex than laboratory-studied models or simple weekday-weekend cycles. Epidemiological evidence on the necessity of acute rebound after restriction remains limited. In this prospective cohort study of 85,618 UK Biobank participants (mean [standard deviation] age 61.8 [7.8] years), we analyze accelerometer-derived sleep data and identify five day-to-day sleep restriction-rebound patterns: regular sleep, sleep restriction (SR) without rebound, SR with rebound, severe SR without rebound, and severe SR with rebound. Associations with all-cause mortality are examined over a median 8.0-year follow-up. Compared to regular sleep, severe SR without rebound is associated with higher mortality risks in the overall sample and across baseline sleep duration groups. SR without rebound is linked to higher mortality overall and in short sleepers. Conversely, neither SR with rebound nor severe SR with rebound is significantly associated with mortality. Results are replicated in an independent cohort from the National Health and Nutrition Examination Survey (N = 4,586). Our findings suggest that short-term SR might be detrimental, particularly for short sleepers, and highlight acute sleep rebound as a potential strategy to mitigate mortality risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.